Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
$21.92
-0.4%
$21.30
$17.45
$70.07
$839.20M0.18894,582 shs367,630 shs
Masimo Corporation stock logo
MASI
Masimo
$167.67
-2.1%
$161.89
$101.61
$194.88
$9.09B1.19638,278 shs498,674 shs
Omnicell, Inc. stock logo
OMCL
Omnicell
$29.56
-0.8%
$29.17
$22.66
$55.75
$1.40B0.76563,657 shs185,031 shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$221.75
+0.2%
$215.83
$187.43
$352.33
$15.97B1.09735,377 shs370,766 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
0.00%+4.93%+9.44%+7.64%-55.57%
Masimo Corporation stock logo
MASI
Masimo
0.00%-0.32%+2.89%+16.11%+46.86%
Omnicell, Inc. stock logo
OMCL
Omnicell
0.00%+0.61%-5.53%-9.58%+10.46%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.00%+1.23%+4.80%+9.23%-31.01%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
4.3143 of 5 stars
3.11.00.04.33.11.71.9
Masimo Corporation stock logo
MASI
Masimo
4.3006 of 5 stars
3.41.00.04.22.72.51.3
Omnicell, Inc. stock logo
OMCL
Omnicell
2.6747 of 5 stars
3.32.00.00.02.31.71.3
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
4.7625 of 5 stars
3.44.01.73.22.41.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
2.25
Hold$32.0846.37% Upside
Masimo Corporation stock logo
MASI
Masimo
2.83
Moderate Buy$191.6014.27% Upside
Omnicell, Inc. stock logo
OMCL
Omnicell
2.57
Moderate Buy$44.8351.67% Upside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.89
Moderate Buy$320.0044.31% Upside

Current Analyst Ratings Breakdown

Latest OMCL, MASI, AMN, and WST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/24/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$245.00
5/23/2025
Omnicell, Inc. stock logo
OMCL
Omnicell
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
5/23/2025
Omnicell, Inc. stock logo
OMCL
Omnicell
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$30.00 ➝ $34.00
5/23/2025
Omnicell, Inc. stock logo
OMCL
Omnicell
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$35.00 ➝ $37.00
5/22/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/14/2025
Omnicell, Inc. stock logo
OMCL
Omnicell
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$31.00 ➝ $35.00
5/13/2025
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$30.00 ➝ $25.50
5/7/2025
Masimo Corporation stock logo
MASI
Masimo
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$193.00
5/7/2025
Masimo Corporation stock logo
MASI
Masimo
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00 ➝ $200.00
5/7/2025
Masimo Corporation stock logo
MASI
Masimo
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$204.00 ➝ $185.00
5/7/2025
Masimo Corporation stock logo
MASI
Masimo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$205.00 ➝ $190.00
(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
$2.98B0.28$13.70 per share1.60$18.56 per share1.18
Masimo Corporation stock logo
MASI
Masimo
$2.09B4.34$6.39 per share26.23$19.50 per share8.60
Omnicell, Inc. stock logo
OMCL
Omnicell
$1.11B1.24$3.03 per share9.75$26.84 per share1.10
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.89B5.51$8.99 per share24.67$37.04 per share5.99
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
-$146.98M-$4.33N/A9.06N/A-5.80%13.39%4.17%8/6/2025 (Estimated)
Masimo Corporation stock logo
MASI
Masimo
-$304.90M-$9.17N/A36.21N/A-25.06%22.56%10.00%8/5/2025 (Estimated)
Omnicell, Inc. stock logo
OMCL
Omnicell
$12.53M$0.4664.2623.84N/A1.87%4.60%2.56%7/30/2025 (Estimated)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$492.70M$6.3734.8128.215.4716.13%18.23%13.51%7/24/2025 (Estimated)

Latest OMCL, MASI, AMN, and WST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/24/2025Q2 2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.51N/AN/AN/A$725.11 millionN/A
5/8/2025Q1 2025
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
$0.19$0.45+$0.26-$0.03$670.08 million$689.53 million
5/6/2025Q1 2025
Masimo Corporation stock logo
MASI
Masimo
$1.24$1.36+$0.12-$3.12$367.79 million$372.00 million
5/6/2025Q1 2025
Omnicell, Inc. stock logo
OMCL
Omnicell
$0.16$0.26+$0.10-$0.15$260.18 million$269.67 million
4/24/2025Q1 2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.22$1.45+$0.23$1.23$685.24 million$698.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
N/AN/AN/AN/AN/A
Masimo Corporation stock logo
MASI
Masimo
N/AN/AN/AN/AN/A
Omnicell, Inc. stock logo
OMCL
Omnicell
N/AN/AN/AN/AN/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.840.38%N/A13.19%N/A

Latest OMCL, MASI, AMN, and WST Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
quarterly$0.210.39%7/30/20257/30/20258/6/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
1.39
1.08
1.08
Masimo Corporation stock logo
MASI
Masimo
0.67
2.17
1.62
Omnicell, Inc. stock logo
OMCL
Omnicell
0.13
1.38
1.23
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.08
2.77
2.03

Institutional Ownership

CompanyInstitutional Ownership
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
99.23%
Masimo Corporation stock logo
MASI
Masimo
85.96%
Omnicell, Inc. stock logo
OMCL
Omnicell
97.70%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%

Insider Ownership

CompanyInsider Ownership
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
0.93%
Masimo Corporation stock logo
MASI
Masimo
9.70%
Omnicell, Inc. stock logo
OMCL
Omnicell
2.52%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.53%
CompanyEmployeesShares OutstandingFree FloatOptionable
AMN Healthcare Services Inc stock logo
AMN
AMN Healthcare Services
4,23038.28 million37.93 millionOptionable
Masimo Corporation stock logo
MASI
Masimo
5,60054.22 million48.96 millionOptionable
Omnicell, Inc. stock logo
OMCL
Omnicell
3,67046.84 million45.66 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,60071.85 million71.46 millionOptionable

Recent News About These Companies

Investors in West Pharmaceutical Services, Inc. ...
West Pharmaceutical Services (WST) Fell on Lowered Guidance

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMN Healthcare Services stock logo

AMN Healthcare Services NYSE:AMN

$21.92 -0.09 (-0.41%)
As of 07/3/2025 03:30 PM Eastern

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including AMN Healthcare, Nursefinders, HealthSource Global Staffing, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in Dallas, Texas.

Masimo stock logo

Masimo NASDAQ:MASI

$167.67 -3.67 (-2.14%)
Closing price 07/3/2025 03:51 PM Eastern
Extended Trading
$167.67 0.00 (0.00%)
As of 07/3/2025 04:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Omnicell stock logo

Omnicell NASDAQ:OMCL

$29.56 -0.24 (-0.81%)
Closing price 07/3/2025 02:32 PM Eastern
Extended Trading
$29.56 +0.00 (+0.00%)
As of 07/3/2025 04:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

West Pharmaceutical Services stock logo

West Pharmaceutical Services NYSE:WST

$221.75 +0.53 (+0.24%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$221.74 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.